Literature DB >> 33584506

COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review.

Tissa Wijeratne1,2,3, Sheila Gillard Crewther1,2, Carmela Sales2,3, Leila Karimi1,2,4.   

Abstract

Clinical reports of neurological manifestations associated with severe coronavirus disease 2019 (COVID-19), such as acute ischemic stroke (AIS), encephalopathy, seizures, headaches, acute necrotizing encephalitis, cerebral microbleeds, posterior reversible leukoencephalopathy syndrome, hemophagocytic lymphohistiocytosis, peripheral neuropathy, cranial nerve palsies, transverse myelitis, and demyelinating disorders, are increasing rapidly. However, there are comparatively few studies investigating the potential impact of immunological responses secondary to hypoxia, oxidative stress, and excessive platelet-induced aggregation on the brain. This scoping review has focused on the pathophysiological mechanisms associated with peripheral and consequential neural (central) inflammation leading to COVID-19-related ischemic strokes. It also highlights the common biological processes shared between AIS and COVID-19 infection and the importance of the recognition that severe respiratory dysfunction and neurological impairments associated with COVID and chronic inflammation [post-COVID-19 neurological syndrome (PCNS)] may significantly impact recovery and ability to benefit from neurorehabilitation. This study provides a comprehensive review of the pathobiology of COVID-19 and ischemic stroke. It also affirms that the immunological contribution to the pathophysiology of COVID-19 is predictive of the neurological sequelae particularly ischemic stroke, which makes it the expectation rather than the exception. This work is of fundamental significance to the neurorehabilitation community given the increasing number of COVID-related ischemic strokes, the current limited knowledge regarding the risk of reinfection, and recent reports of a PCNS. It further highlights the need for global collaboration and research into new pathobiology-based neurorehabilitation treatment strategies and more integrated evidence-based care.
Copyright © 2021 Wijeratne, Gillard Crewther, Sales and Karimi.

Entities:  

Keywords:  ACE2; COVID-19; PCNS; cytokines; pathogen associated molecular pattern; post Covid19 neurology syndrome; stroke

Year:  2021        PMID: 33584506      PMCID: PMC7876298          DOI: 10.3389/fneur.2020.607221

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  156 in total

1.  Stroke Risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases.

Authors:  Sebastian Fridman; Maria Bres Bullrich; Amado Jimenez-Ruiz; Pablo Costantini; Palak Shah; Caroline Just; Daniel Vela-Duarte; Italo Linfante; Athena Sharifi-Razavi; Narges Karimi; Rodrigo Bagur; Derek B Debicki; Teneille E Gofton; David A Steven; Luciano A Sposato
Journal:  Neurology       Date:  2020-09-15       Impact factor: 9.910

2.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

3.  Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans.

Authors:  Constantin F Urban; David Ermert; Monika Schmid; Ulrike Abu-Abed; Christian Goosmann; Wolfgang Nacken; Volker Brinkmann; Peter R Jungblut; Arturo Zychlinsky
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

4.  Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension.

Authors:  Kazushi Tsuda
Journal:  Int J Hypertens       Date:  2012-11-21       Impact factor: 2.420

Review 5.  Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.

Authors:  Paola Toniati; Simone Piva; Marco Cattalini; Emirena Garrafa; Francesca Regola; Francesco Castelli; Franco Franceschini; Paolo Airò; Chiara Bazzani; Eva-Andrea Beindorf; Marialma Berlendis; Michela Bezzi; Nicola Bossini; Maurizio Castellano; Sergio Cattaneo; Ilaria Cavazzana; Giovanni-Battista Contessi; Massimo Crippa; Andrea Delbarba; Elena De Peri; Angela Faletti; Matteo Filippini; Matteo Filippini; Micol Frassi; Mario Gaggiotti; Roberto Gorla; Michael Lanspa; Silvia Lorenzotti; Rosa Marino; Roberto Maroldi; Marco Metra; Alberto Matteelli; Denise Modina; Giovanni Moioli; Giovanni Montani; Maria-Lorenza Muiesan; Silvia Odolini; Elena Peli; Silvia Pesenti; Maria-Chiara Pezzoli; Ilenia Pirola; Alessandro Pozzi; Alessandro Proto; Francesco-Antonio Rasulo; Giulia Renisi; Chiara Ricci; Damiano Rizzoni; Giuseppe Romanelli; Mara Rossi; Massimo Salvetti; Francesco Scolari; Liana Signorini; Marco Taglietti; Gabriele Tomasoni; Lina-Rachele Tomasoni; Fabio Turla; Alberto Valsecchi; Davide Zani; Francesco Zuccalà; Fiammetta Zunica; Emanuele Focà; Laura Andreoli; Nicola Latronico
Journal:  Autoimmun Rev       Date:  2020-05-03       Impact factor: 9.754

6.  Stroke in patients with SARS-CoV-2 infection: case series.

Authors:  Mauro Morassi; Daniele Bagatto; Milena Cobelli; Serena D'Agostini; Gian Luigi Gigli; Claudio Bnà; Alberto Vogrig
Journal:  J Neurol       Date:  2020-05-20       Impact factor: 6.682

7.  Evaluation of neutrophil extracellular traps as the circulating marker for patients with acute coronary syndrome and acute ischemic stroke.

Authors:  Hyeon-Ho Lim; In-Hwa Jeong; Gyu-Dae An; Kwang-Sook Woo; Kyeong-Hee Kim; Jeong-Man Kim; Seong-Hoon Yun; Joo-In Park; Jae-Kwan Cha; Moo-Hyun Kim; Jin-Yeong Han
Journal:  J Clin Lab Anal       Date:  2020-01-06       Impact factor: 2.352

Review 8.  Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.

Authors:  Souhel Najjar; Amanda Najjar; Derek J Chong; Bidyut K Pramanik; Claudia Kirsch; Ruben I Kuzniecky; Steven V Pacia; Salman Azhar
Journal:  J Neuroinflammation       Date:  2020-08-06       Impact factor: 8.322

View more
  18 in total

1.  AstraZeneca COVID-19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series.

Authors:  Amira Siddig; Khabab Abbasher Hussien Mohamed Ahmed; Mazin S Hassan Haroun; Abdallah M Abdallah; Mohamed Malekaldar; Al Hussien Abbasher; Mohammed Abbasher; Abubaker Alsedig Abbasher; Abbasher Hussien
Journal:  Clin Case Rep       Date:  2022-07-11

Review 2.  Systematic Review of Existing Stroke Guidelines: Case for a Change.

Authors:  Tissa Wijeratne; Carmela Sales; Chanith Wijeratne; Leila Karimi; Mihajlo Jakovljevic
Journal:  Biomed Res Int       Date:  2022-06-15       Impact factor: 3.246

Review 3.  Post-COVID 19 neurological syndrome: Implications for sequelae's treatment.

Authors:  William Camargo-Martínez; Ivan Lozada-Martínez; Angie Escobar-Collazos; Aura Navarro-Coronado; Luis Moscote-Salazar; Alfonso Pacheco-Hernández; Tariq Janjua; Pilar Bosque-Varela
Journal:  J Clin Neurosci       Date:  2021-04-08       Impact factor: 1.961

Review 4.  Neurological Complications of COVID-19: Underlying Mechanisms and Management.

Authors:  Ghaydaa A Shehata; Kevin C Lord; Michaela C Grudzinski; Mohamed Elsayed; Ramy Abdelnaby; Hatem A Elshabrawy
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

5.  Severe stroke in patients admitted to intensive care unit after COVID-19 infection: Pictorial essay of a case series.

Authors:  Cristian Deana; Daniele Bagatto
Journal:  Brain Hemorrhages       Date:  2021-12-13

Review 6.  Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge.

Authors:  Domenico Nuzzo; Sonya Vasto; Luca Scalisi; Salvatore Cottone; Gaetano Cambula; Manfredi Rizzo; Daniela Giacomazza; Pasquale Picone
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

Review 7.  Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.

Authors:  Giuliano Ramadori
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  Potentials to alleviate coagulopathy and enhance microglial function of beta (β)- glucans, making them worth a clinical study for COVID-19's neurological sequalae.

Authors:  Kadalraja Raghavan; Ramesh Shankar Kandaswamy; Nobunao Ikewaki; Masaru Iwasaki; Samuel J K Abraham
Journal:  J Neurol Sci       Date:  2021-06-22       Impact factor: 3.181

9.  Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study.

Authors:  Doaa A Mekkawy; Sherif Hamdy; Maged Abdel-Naseer; Hatem S Shehata; Ahmed Al Halfawy; Nevin M Shalaby; Ghaydaa A Shehata; Anwar M Ali; Alaa Elmazny; Sandra M Ahmed; Jumana H Ismail; Aml Ibraheim; Hoda M Abdel-Hamid; Rehab Magdy; Younan Kabara Ayoub; Ahmed E Taha; Nahla Merghany; Nourhan M Soliman; Haidy Elshebawy; Samar E S Abdelal; Lobna El-Ghoneimy; Aussan Al-Athwari; Nirmeen A Kishk; Mona A F Nada; Marwa Farghaly; Amr Hassan; Mohamed I Hegazy; Ahmed Abdelalim; Husam S Mourad; Amira Hassouna; Alshimaa S Othman; Tissa Wijeratne
Journal:  Brain Sci       Date:  2022-01-01

10.  [Ischemic stroke in coronavirus disease 2019].

Authors:  Paulina Laura Sander; Ulrich Cleff; Simon Larrossa-Lombardi; Hatem Ali; Panagiotis Fotiadis; Gernot Reimann; Stefan Rohde; Ulrich Hofstadt-van Oy
Journal:  Internist (Berl)       Date:  2021-08-02       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.